![René Vleugels](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von René Vleugels
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NovoVacs BV | Gründer | 01.09.2009 | - |
CyTuVax BV
![]() CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | Vorstandsvorsitzender | 01.01.2011 | - |
Gründer | 01.01.2011 | - |
Karriereverlauf von René Vleugels
Ehemalige bekannte Positionen von René Vleugels
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Maastricht University | Corporate Officer/Principal | - | - |
AdjuTec BV
![]() AdjuTec BV Pharmaceuticals: MajorHealth Technology AdjuTec BV is a Dutch company that manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients. The company is based in Maastricht, Netherlands. The company was founded in 2017 by René Vleugels. | Gründer | 01.01.2017 | - |
MUbio Holding BV
![]() MUbio Holding BV BiotechnologyHealth Technology MUbio Products B.V. (MUbio) is a privately owned Dutch biotech company, founded in 2000 by Dr. R. Vleugels and Prof. Dr. F. Ramaekers. The company originated as a spin out from the Department of Molecular Cell Biology of the Maastricht University. MUbio produces high quality reagents and bioassays for cell biology and biomedical research. MUbio's product portfolio includes an increasing number of well-characterized antibodies for oncology research, produced in an ISO certified laboratory. MUbio’s partnered and proprietary R&D projects focus on the identification and validation of cancer biomarkers, development of lung cancer diagnostic kits & research and development of a lung cancer vaccine. | Gründer | 01.09.2009 | - |
Präsident | 01.01.2000 | - |
Ausbildung von René Vleugels
Radboud University Nijmegen | Doctorate Degree |
Statistik
International
Niederlande | 7 |
Operativ
Founder | 4 |
President | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
MUbio Holding BV
![]() MUbio Holding BV BiotechnologyHealth Technology MUbio Products B.V. (MUbio) is a privately owned Dutch biotech company, founded in 2000 by Dr. R. Vleugels and Prof. Dr. F. Ramaekers. The company originated as a spin out from the Department of Molecular Cell Biology of the Maastricht University. MUbio produces high quality reagents and bioassays for cell biology and biomedical research. MUbio's product portfolio includes an increasing number of well-characterized antibodies for oncology research, produced in an ISO certified laboratory. MUbio’s partnered and proprietary R&D projects focus on the identification and validation of cancer biomarkers, development of lung cancer diagnostic kits & research and development of a lung cancer vaccine. | Health Technology |
NovoVacs BV | |
CyTuVax BV
![]() CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |
AdjuTec BV
![]() AdjuTec BV Pharmaceuticals: MajorHealth Technology AdjuTec BV is a Dutch company that manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients. The company is based in Maastricht, Netherlands. The company was founded in 2017 by René Vleugels. | Health Technology |
- Börse
- Insiders
- René Vleugels
- Erfahrung